Patents Represented by Attorney, Agent or Law Firm Margaret C. Bogosian
-
Patent number: 5926772Abstract: The present invention provides a composition and process for disposal of radioactive, hazardous and mixed wastes. The present invention preferably includes a process for multibarrier encapsulation of radioactive, hazardous and mixed wastes by combining substantially simultaneously dry waste powder, a non-biodegradable thermoplastic polymer and an anhydrous additive in an extruder to form a homogenous molten matrix. The molten matrix may be directed in a "clean" polyethylene liner, allowed to cool, thus forming a monolithic waste form which provides a multibarrier to the dispersion of wastes into the environment.Type: GrantFiled: October 14, 1997Date of Patent: July 20, 1999Assignee: Brookhaven Science Associates LLCInventors: Paul D. Kalb, Peter Colombo
-
Patent number: 5917874Abstract: A target includes a body having a depression in a front side for holding a sample for irradiation by a particle beam to produce a radioisotope. Cooling fins are disposed on a backside of the body opposite the depression. A foil is joined to the body front side to cover the depression and sample therein. A perforate grid is joined to the body atop the foil for supporting the foil and for transmitting the particle beam therethrough. A coolant is circulated over the fins to cool the body during the particle beam irradiation of the sample in the depression.Type: GrantFiled: January 20, 1998Date of Patent: June 29, 1999Assignee: Brookhaven Science AssociatesInventors: David J. Schlyer, Richard A. Ferrieri, Conrad Koehler
-
Patent number: 5888790Abstract: Disclosed is a method for modifying the chain length and double bond positional specificities of a soluble plant fatty acid desaturase. More specifically, the method involves modifying amino acid contact residues in the substrate binding channel of the soluble fatty acid desaturase which contact the fatty acid. Specifically disclosed is the modification of an acyl-ACP desaturase. Amino acid contact residues which lie within the substrate binding channel are identified, and subsequently replaced with different residues to effect the modification of activity.Type: GrantFiled: May 9, 1997Date of Patent: March 30, 1999Assignee: Brookhaven Science Associates LLCInventors: Edgar B. Cahoon, John Shanklin, Ylva Lindqvist, Gunter Schneider
-
Patent number: 5885825Abstract: A method of biochemically transforming macromolecular compounds found in solid carbonaceous materials, such as coal is provided. The preparation of new microorganisms, metabolically weaned through challenge growth processes to biochemically transform solid carbonaceous materials at extreme temperatures, pressures, pH, salt and toxic metal concentrations is also disclosed.Type: GrantFiled: November 23, 1994Date of Patent: March 23, 1999Assignee: Brookhaven Science AssociatesInventors: Mow S. Lin, Eugene T. Premuzic
-
Patent number: 5880045Abstract: Lead-free phosphate glass compositions are provided which can be used to immobilize low level and/or high level radioactive wastes in monolithic waste forms. The glass composition may also be used without waste contained therein. Lead-free phosphate glass compositions prepared at about 900.degree. C. include mixtures from about 1 mole % to about 6 mole %.iron (III) oxide, from about 1 mole % to about 6 mole % aluminum oxide, from about 15 mole % to about 20 mole % sodium oxide or potassium oxide, and from about 30 mole % to about 60 mole % phosphate. The invention also provides phosphate, lead-free glass ceramic glass compositions which are prepared from about 400.degree. C. to about 450.degree. C. and which includes from about 3 mole % to about 6 mole % sodium oxide, from about 20 mole % to about 50 mole % tin oxide, from about 30 mole % to about 70 mole % phosphate, from about 3 mole % to about 6 mole % aluminum oxide, from about 3 mole % to about 8 mole % silicon oxide, from about 0.Type: GrantFiled: July 27, 1998Date of Patent: March 9, 1999Assignee: Brookhaven Science AssociatesInventors: Hui Cao, Jay W. Adams, Paul D. Kalb
-
Patent number: 5877165Abstract: The present invention covers boronated porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies such as boron neutron capture therapy and photodynamic therapy.Type: GrantFiled: June 13, 1997Date of Patent: March 2, 1999Assignee: Brookhaven Science AssociatesInventors: Michiko Miura, John A. Shelnutt, Daniel N. Slatkin
-
Patent number: 5870447Abstract: A particle accelerator (12) generates an input particle beam having an initial energy level above a threshold for generating secondary nuclear particles. A thin target (14) is rotated in the path of the input beam for undergoing nuclear reactions to generate the secondary particles and correspondingly decrease energy of the input beam to about the threshold. The target (14) produces low energy secondary particles and is effectively cooled by radiation and conduction. A neutron scatterer (44) and a neutron filter (42) are also used for preferentially degrading the secondary particles into a lower energy range if desired.Type: GrantFiled: December 30, 1996Date of Patent: February 9, 1999Assignee: Brookhaven Science AssociatesInventors: James R. Powell, Morris Reich, Hans Ludewig, Michael Todosow
-
Patent number: 5869320Abstract: This application describes a means to clone a functional gene for bacteriophage T7 RNA polymerase. Active T7 RNA polymerase is produced from the cloned gene, and a plasmid has been constructed that can produce the active enzyme in large amounts. T7 RNA polymerase transcribes DNA very efficiently and is highly selective for a relatively long promoter sequence. This enzyme is useful for synthesizing large amounts of RNA in vivo or in vitro, and is capable of producing a single RNA selectively from a complex mixture of DNAs. The procedure used to obtain a clone of the R7 RNA polymerase gene can be applied to other T7-like phages to obtain clones that produce RNA polymerases having different promoter specificities, different bacterial hosts, or other desirable properties. T7 RNA polymerase is also used in a system for selective, high-level synthesis of RNAs and proteins in suitable host cells.Type: GrantFiled: January 15, 1997Date of Patent: February 9, 1999Assignee: Brookhaven Science Associates LLCInventors: F. William Studier, Parichehre Davanloo, Alan H. Rosenberg, Barbara A. Moffatt, John J. Dunn
-
Patent number: 5858766Abstract: A process for biochemical conversion of heavy crude oils is provided. The process includes contacting heavy crude oils with adapted biocatalysts. The resulting upgraded oil shows, a relative increase in saturated hydrocarbons, emulsions and oxygenates and a decrease in compounds containing in organic sulfur, organic nitrogen and trace metals. Adapted microorganisms which have been modified under challenged growth processes are also disclosed.Type: GrantFiled: November 18, 1996Date of Patent: January 12, 1999Assignee: Brookhaven Science AssociatesInventors: Eugene T. Premuzic, Mow S. Lin
-
Patent number: 5853695Abstract: The invention provides a method for the palliation of bone pain due to cancer by the administration of a unique dosage of a tin-117m (Sn-117m) stannic chelate complex in a pharmaceutically acceptable composition. In addition, the invention provides a method for simultaneous palliation of bone pain and radiotherapy in cancer patients using compositions containing Sn-117m chelates. The invention also provides a method for palliating bone pain in cancer patients using Sn-117m-containing compositions and monitoring patient status by imaging the distribution of the Sn-117m in the patients. Also provided are pharmaceutically acceptable compositions containing Sn-117m chelate complexes for the palliation of bone pain in cancer patients.Type: GrantFiled: November 4, 1996Date of Patent: December 29, 1998Assignee: Brookhaven Science Associates LLCInventors: Suresh C. Srivastava, George E. Meinken, Leonard F. Mausner, Harold L. Atkins
-
Patent number: 5844058Abstract: A new family of polysaccharide graft polymers are provided as corrosion resistant coatings having antimicrobial properties which are useful on light metals such as aluminum, magnesium, zinc, steel and their alloys. Methods of making the polysaccharide graft polymers are also included. The methods of making the polysaccharide graft polymers involve reacting a polysaccharide source with an antimicrobial agent under conditions of hydrolysis-condensation.Type: GrantFiled: December 17, 1996Date of Patent: December 1, 1998Assignee: Brookhaven Science AssociatesInventor: Toshifumi Sugama
-
Patent number: 5840182Abstract: An apparatus is disclosed for containing a microorganism culture in an active exponential growth and delivering a supply of microorganisms to an environment containing wastes for bio-augmenting the biodegradation of the wastes. The apparatus comprises a bioreactor and an operably connected controller. The bioreactor has a bioreactor chamber for containing a supply of microorganisms, a second chamber for containing a supply of water and inorganic nutrients, and a third chamber for containing a supply of organic nutrients. The bioreactor is operably connected to the controller in which a first pump is operably connected in fluid communication between the bioreactor chamber and the second chamber and third chamber, and a second pump is operably connected in fluid communication between the bioreactor chamber and the environment containing wastes to be biodegraded.Type: GrantFiled: June 3, 1997Date of Patent: November 24, 1998Assignee: Brookhaven Science Associates LLCInventors: John A. Lucido, Daniel Keenan, Eugene T. Premuzic, Mow S. Lin, Ludmila Shelenkova
-
Patent number: 5840638Abstract: Lead-free phosphate glass compositions are provided which can be used to immobilize low level and/or high level radioactive wastes in monolithic waste forms. The glass composition may also be used without waste contained therein. Lead-free phosphate glass compositions prepared at about 900.degree. C. include mixtures from about 1 mole % to about 6 mole % iron (III) oxide, from about 1 mole % to about 6 mole % aluminum oxide, from about 15 mole % to about 20 mole % sodium oxide or potassium oxide, and from about 30 mole % to about 60 mole % phosphate. The invention also provides phosphate, lead-free glass ceramic glass compositions which are prepared from about 400.degree. C. to about 450.degree. C. and which includes from about 3 mole % to about 6 mole % sodium oxide, from about 20 mole % to about 50 mole % tin oxide, from about 30 mole % to about 70 mole % phosphate, from about 3 mole % to about 6 mole % aluminum oxide, from about 3 mole % to about 8 mole % silicon oxide, from about 0.Type: GrantFiled: December 23, 1996Date of Patent: November 24, 1998Assignee: Brookhaven Science AssociatesInventors: Hui Cao, Jay W. Adams, Paul D. Kalb
-
Patent number: 5830694Abstract: This invention relates to the cloning and expression of autogenes encoding RNA polymerases of T7 and T7-like bacteriophages, in which the RNA polymerase gene is transcribed from a promoter which is recognized by the encoded RNA polymerase. Cloning of T7 autogenes was achieved by reducing the activity of the RNA polymerase sufficiently to permit host cell growth. T7 RNA polymerase activity was controlled by combining two independent methods: lac-repression of the recombinant lac operator-T7 promoter in the autogene and inhibition of the polymerase by T7 lysozyme. Expression systems for producing the RNA polymerases of T7 and other T7-like bacteriophages, and expression systems for producing selected gene products are described, as well as other related materials and methods.Type: GrantFiled: November 8, 1996Date of Patent: November 3, 1998Assignee: Associated Universities, Inc.Inventors: F. William Studier, John W. Dubendorff
-
Patent number: 5824528Abstract: This invention relates to the cloning and expression of autogenes encoding RNA polymerases of T7 and T7-like bacteriophages, in which the RNA polymerase gene is transcribed from a promoter which is recognized by the encoded RNA polymerase. Cloning of T7 autogenes was achieved by reducing the activity of the RNA polymerase sufficiently to permit host cell growth. T7 RNA polymerase activity was controlled by combining two independent methods: lac-repression of the recombinant lac operator-T7 promoter in the autogene and inhibition of the polymerase by T7 lysozyme. Expression systems for producing the RNA polymerases of T7 and other T7-like bacteriophages, and expression systems for producing selected gene products are described, as well as other related materials and methods.Type: GrantFiled: August 15, 1994Date of Patent: October 20, 1998Assignee: Associated Universities, Inc.Inventors: F. William Studier, John W. Dubendorff
-
Patent number: 5818050Abstract: A method of uncollimated single photon emission computed tomography includes administering a radioisotope to a patient for producing gamma ray photons from a source inside the patient. Emissivity of the photons is measured externally of the patient with an uncollimated gamma camera at a plurality of measurement positions surrounding the patient for obtaining corresponding energy spectrums thereat. Photon emissivity at the plurality of measurement positions is predicted using an initial prediction of an image of the source. The predicted and measured photon emissivities are compared to obtain differences therebetween. Prediction and comparison is iterated by updating the image prediction until the differences are below a threshold for obtaining a final prediction of the source image.Type: GrantFiled: April 7, 1997Date of Patent: October 6, 1998Assignee: Brookhaven Science Associates LLCInventors: F. Avraham Dilmanian, Randall L. Barbour
-
Patent number: 5808020Abstract: Apparatus for performing organic synthetic reactions, particularly no-carrier-added nucleophilic radiofluorination reactions for PET radiotracer production. The apparatus includes an optical reaction cell and a source of broadband infrared radiant energy, which permits direct coupling of the emitted radiant energy with the reaction medium to heat the reaction medium. Preferably, the apparatus includes means for focusing the emitted radiant energy into the reaction cell, and the reaction cell itself is preferably configured to reflect transmitted radiant energy back into the reaction medium to further improve the efficiency of the apparatus. The apparatus is well suited to the production of high-yield syntheses of 2-?.sup.18 F!fluoro-2-deoxy-D-glucose. Also provided is a method for performing organic synthetic reactions, including the manufacture of ?.sup.18 F!-labeled compounds useful as PET radiotracers, and particularly for the preparation of 2-?.sup.Type: GrantFiled: August 12, 1996Date of Patent: September 15, 1998Assignee: Associated Universities, Inc.Inventors: Richard A. Ferrieri, David Schlyer, Richard J. Becker
-
Patent number: 5793254Abstract: A monolithic amplifier includes a stable, high resistance feedback circuit and a dynamic bias circuit. The dynamic bias circuit is formed with active elements matched to those in the amplifier and feedback circuit to compensate for variations in the operating and threshold voltages thereby maintaining a stable resistance in the feedback circuit.Type: GrantFiled: September 24, 1996Date of Patent: August 11, 1998Assignee: Brookhaven Science Associates LLCInventor: Paul O'Connor
-
Patent number: 5789585Abstract: A family of aza-ether based compounds including linear, multi-branched and aza-crown ethers is provided. When added to non-aqueous battery electrolytes, the new family of aza-ether based compounds acts as neutral receptors to complex the anion moiety of the electrolyte salt thereby increasing the conductivity and the transference number of LI.sup.+ ion in alkali metal batteries.Type: GrantFiled: May 23, 1997Date of Patent: August 4, 1998Assignee: Brookhaven Science Associates LLCInventors: Hung Sui Lee, Xiao-Oing Yang, James McBreen
-
Patent number: 5788504Abstract: A Computerized Training Management System (CTMS) for providing a procedurally defined process that is employed to develop accreditable performance based training programs for job classifications that are sensitive to documented regulations and technical information. CTMS is a database that links information needed to maintain a five-phase approach to training-analysis, design, development, implementation, and evaluation independent of training program design. CTMS is designed using R-Base.RTM., an-SQL compliant software platform. Information is logically entered and linked in CTMS. Each task is linked directly to a performance objective, which, in turn, is linked directly to a learning objective; then, each enabling objective is linked to its respective test items. In addition, tasks, performance objectives, enabling objectives, and test items are linked to their associated reference documents.Type: GrantFiled: October 16, 1995Date of Patent: August 4, 1998Assignee: Brookhaven Science Associates LLCInventors: Harold B. Rice, Robert C. McNair, Kenneth White, Terry Maugeri